Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion type Assertion NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_head.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion description "[Decreased levels of pRb2/p130 in endometrial cancer cells was significantly associated with a decreased probability of remaining disease-free after treatment (P = .003) and with decreased probability of survival (P < .0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_provenance.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion evidence source_evidence_literature NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_provenance.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion SIO_000772 9508194 NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_provenance.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion wasDerivedFrom befree-2016 NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_provenance.
- NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_assertion wasGeneratedBy ECO_0000203 NP1390926.RA4xdO2jc-PS25naFUpwLNM9tQij9yAY-BV9FiuCWjhxc130_provenance.